Handelsbanken Fonder’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.12M | Sell |
253,208
-180,280
| -42% | -$6.5M | 0.03% | 361 |
|
|
2025
Q1 | $13.5M | Sell |
433,488
-26,695
| -6% | -$831K | 0.06% | 292 |
|
|
2024
Q4 | $11.7M | Sell |
460,183
-261,144
| -36% | -$6.66M | 0.04% | 331 |
|
|
2024
Q3 | $20.4M | Buy |
721,327
+6,298
| +0.9% | +$178K | 0.08% | 228 |
|
|
2024
Q2 | $18.9M | Buy |
715,029
+33,728
| +5% | +$889K | 0.08% | 220 |
|
|
2024
Q1 | $20.7M | Sell |
681,301
-210,617
| -24% | -$6.4M | 0.09% | 213 |
|
|
2023
Q4 | $25.1M | Sell |
891,918
-39,718
| -4% | -$1.12M | 0.12% | 181 |
|
|
2023
Q3 | $25.3M | Buy |
931,636
+140,300
| +18% | +$3.81M | 0.14% | 165 |
|
|
2023
Q2 | $24.3M | Buy |
791,336
+85,802
| +12% | +$2.64M | 0.13% | 175 |
|
|
2023
Q1 | $25.4M | Buy |
705,534
+95,081
| +16% | +$3.43M | 0.15% | 167 |
|
|
2022
Q4 | $24.1M | Buy |
610,453
+471,553
| +339% | +$18.6M | 0.15% | 165 |
|
|
2022
Q3 | $5.58M | Buy |
138,900
+89,700
| +182% | +$3.6M | 0.04% | 388 |
|
|
2022
Q2 | $2.07M | Buy |
49,200
+6,600
| +15% | +$277K | 0.01% | 526 |
|
|
2022
Q1 | $1.66M | Buy |
42,600
+8,800
| +26% | +$343K | 0.01% | 623 |
|
|
2021
Q4 | $1.35M | Hold |
33,800
| – | – | 0.01% | 758 |
|
|
2021
Q3 | $1.22M | Buy |
33,800
+18,900
| +127% | +$683K | 0.01% | 797 |
|
|
2021
Q2 | $459K | Buy |
+14,900
| New | +$459K | ﹤0.01% | 1437 |
|
|
2021
Q1 | – | Sell |
-8,144
| Closed | -$408K | – | 1585 |
|
|
2020
Q4 | $408K | Buy |
+8,144
| New | +$408K | ﹤0.01% | 1265 |
|